← FDA Drug Approvals (Drugs@FDA)

METHYLPREDNISOLONE SODIUM SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TIANJIN KINGYORK · Approved 2021-04-20

Drug application

FDA Application #
ANDA212396
Application type
Abbreviated New Drug Application (Generic)
Brand name
METHYLPREDNISOLONE SODIUM SUCCINATE
Generic name
METHYLPREDNISOLONE SODIUM SUCCINATE
Active ingredients
METHYLPREDNISOLONE SODIUM SUCCINATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
TIANJIN KINGYORK
Manufacturer
Dr. Reddy's Laboratories Inc
First approval
2021-04-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown